The characterization and classification of neurotransmitter receptors

Annals of the New York Academy of Sciences

Volumn 812, Issue , 1997, Pages 1-13

  Humphrey, Patrick P A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; DOPAMINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC RECEPTOR; NEUROTRANSMITTER RECEPTOR; PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN RECEPTOR;

AMINO ACID SEQUENCE; DRUG RECEPTOR BINDING; HUMAN; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0030746388     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48141.x     Document Type: Review

References (63)

1. HIMMELWEIT, F. 1960. The collected papers of Paul Ehrlich, Vol. III, Chemotherapy. Edited and compiled by F. Himmelweit.
2. CLAUDIO, T. 1986. Recombinant DNA technology in the study of ion channels. Trends Pharmacol. Sci. 7: 308-312.
3. DE JONGH, D. K. 1964. A molecular approach to general pharmacology. In Molecular Pharmacology - The Mode of Action of Biologically Active Compounds, Vol. I. E. J. Ariens, Ed. Academic Press. New York/London, p. 16.
4. MILLS, A. & M. J. DUGGAN. 1993. Orphan seven transmembrane domain receptors: Reversing pharmacology. Trends Pharmacol. Sci. 14: 394-396.
5. 1 receptor. Nature 377: 532-534.
6. STEPHENSON, R. P. 1975. Interaction of agonists and antagonists with their receptors. INSERM 50: 15-28.
7. ROLE, L. W. 1992. Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr. Opin. Neurobiol. 2: 254-262.
8. MONYER, H., R. SPRENGEL, R. SCHOEPFER, A. HERB, M. HIGUCHI, H. LOMELI, N. BURNASHEV, B. SAKMANN & P. H. SEEBURG. 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221.
9. SCHWARTZ, T. W. 1994. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotech. 5: 434-444.
10. 2 dopamine receptor isoforms. Nature 342: 923-926.
11. EPELBAUM, J., P. DOURNAUD, M. FODOR & C. VIOLLET. 1994. The neurobiology of somatostatin. Crit. Rev. Neurobiol. 8: 25-44.
12. 3 R-A subunit expressed in xenopus laevis oocytes. Neuropharmacology 33: 473-482.
13. 4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J. 14: 2806-2815.
14. HOUSLEY, G. D., D. GREENWOOD, T. BENNETT & A. F. RYAN. 1995. Identification of a short form of the P2XR1-purinoceptor subunit produced by alternative splicing in the pituitary and cochlea. Biochem. Biophys. Res. Commun. 212: 501-508.
15. REGOLI, D., A. BOUDON & J.-C. FAUCHERE. 1994. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46: 551-599.
16. BIRNBAUMER, L., J. ABRAMOWITZ, A. YATANI, K. OKABE, R. MATTERA, R. GRAF, J. SANFORD, J. CODINA & A. M. BROWN. 1990. Roles of G proteins in coupling of receptors to ionic channels and other effector systems. Crit. Rev. Biochem. Mol. Biol. 25: 225-244.
17. 1B receptors. Nature 360: 161-163.
18. 1 receptor for substance P and a non-peptide antagonist. Nature 362: 345-347.
19. GINGRICH, J. A. & M. G. CARON. 1993. Recent advances in the molecular biology of dopamine receptors. Ann. Rev. Neurosci. 16: 299-321.
20. SARGENT, P. B. 1993. The diversity of neuronal nicotinic receptors. Ann. Rev. Neurosci. 16: 403-443.
21. AHLQUIST, R. P. 1948. A study of the adrenergic receptors. Am. J. Physiol. 153: 586-600.
22. NICKERSON, M. 1949. The pharmacology of adrenergic blockade. Pharmacol. Rev. 1: 27-101.
23. BLACK, J. W. & J. S. STEPHENSON. 1962. Pharmacology of a new adrenergic β-receptor blocking compound. Lancet 2: 311-314.
24. DOXEY, J. C., C. F. C. SMITH & J. M. WALKER. 1977. Selectivity of blocking agents for pre- and postsynaptic α-adrenoceptors. Br. J. Pharmacol. 60: 91-96.
25. BLACK, J. W. 1990. Development of ideas about noradrenaline receptors. In The Heyman Institute of Pharmacology 1890-1990. A. F. De Shaepdryver, Ed. Heymans Foundation. Ghent, Belgium, pp. 109-115.
26. LANDS, A. M., A. ARNOLD, J. P. MCAULIFF, F. P. LUDUENA & T. G. BROWN, JR. 1967. Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597-598.
27. 2-adrenergic receptor. Proc. Natl. Acad. Sci. USA 85: 9494-9498.
28. ASH, A. S. F. & H. O. SCHILD. 1966. Receptors mediating some actions of histamine. Br. J. Pharmacol. 27: 427-439.
29. BLACK, J. W., W. A. M. DUNCAN, C. J. DURANT, C. R. GANELLIN & E. M. PARSONS. 1972. Definition and antagonism of histamine H2-receptors. Nature 236: 385-390.
30. HOYER, D., D. E. CLARKE, J. R. FOZARD, P. R. HARTIG, G. R. MARTIN, E. J. MYLECHARANE, P. R. SAXENA & P. P. A. HUMPHREY. 1994. VII. International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol. Rev. 46: 157-203.
31. COLEMAN, R. A., W. L. SMITH & S. NARUMIYA. 1994. VIII. International Union of Pharmacology Classification of Prostanoid Receptors: Properties, Distribution, and Structure of the Receptors and their Subtypes. Pharmacol. Rev. 46: 205-229.
32. FREDHOLM, B. B., M. P. ABBRACCHIO, G. BURNSTOCK, J. W. DALY, T. K. HARDEN, K. A. JACOBSON, P. LEFF & M. WILLIAMS. 1994. VI. International Union of Pharmacology Nomenclature and Classification of Purinoceptors. Pharmacol. Rev. 46: 143-156.
33. HUMPHREY, P. P. A. 1984. Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology 23: 1503-1510.
34. BRADLEY, P. B., G. ENGEL, W. FENIUK, J. R. FOZARD, P. P. A. HUMPHREY, D. N. MIDDLEMISS, E. J. MYLECHARANE, B. PRICHARDSON & P. R. SAXENA. 1986. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563-576.
35. HUMPHREY, P. P. A., P. HARTIG & D. HOYER. 1993. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14: 233-236.
36. MARTIN, G. R. & P. P. A. HUMPHREY. 1994. Receptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 33: 261-273.
37. 1D receptor subtypes. Trends Pharmacol. Sci. 17: 103-105.
38. HUMPHREY, P. P. A., M. SPEDDING & P. M. VANHOUTTE. 1994. Receptor classification and nomenclature: The revolution and the resolution. Trends Pharmacol. Sci. 15:203-204.
39. SACHAIS, B. S., R. M. SNIDER, J. A. LOWE III & J. E. KRAUSE. 1993. Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J. Biol. Chem. 268: 2319-2323.
40. 1F receptors for β-adrenergic antagonists. Neuropharmacology 33: 387-391.
41. KENAKIN, T. 1995a. Agonist-receptor efficacy I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 16: 188-192.
42. KENAKIN, T. 1995b. Agonist-receptor efficacy II: Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16: 232-238.
43. KENAKIN, T. P., R. A. BOND & T. I. BONNER. 1992. Definition of pharmacological receptors. Pharmacol. Rev. 44: 351-362.
44. PROBST, W. C., L. A. SNYDER, D. I. SCHUSTER, J. BROSIUS & S. C. SEALFON. 1992. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 11: 1-20.
45. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377: 432-435.
46. DOHLMAN, H., M. CARON & R. J. LEFKOWITZ. 1987. A family of receptors coupled to guanine nucleotide regulating proteins. Biochem. 26: 2657-2664.
47. 1D receptor genes. Trends Pharmacol. Sci. 13: 152-159.
48. HALL, J. M., M. P. CAULFIELD, S. P. WATSON & S. GUARD. 1993. Receptor subtypes or species homologues: relevance to drug discovery. Trends Pharmacol. Sci. 14: 376-383.
49. HOYER, D., H. LÜBBERT & C. BRUNS. 1994. Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 350: 441-453.
50. REISINE, T. & G. I. BELL. 1995. Molecular biology of somatostatin receptors. Endocrine Rev. 16: 427-442.
51. JACKSON, T. 1991. Structure and function of G protein coupled receptors. Pharmac. Ther. 50: 425-442.
52. MILLIGAN, G. 1993. Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 14: 239-244.
53. WATSON, S. & S. ARKINSTALL. 1994. The G-protein linked receptor. Factsbook, Academic Press.
54. KLEUSS, C., H. SCHERUBL, J. HESCHELER, G. SCHULTZ & B. WITTIG. 1993. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins. Science 259: 832-834.
55. 2 receptors expressed in different cell types. J. Biol. Chem. 265: 10320-10326.
56. BIRNBAUMER, L. & M. BIRNBAUMER. 1994. Signal transduction by G proteins. J. Rec. Sig. Trans. Res. 15: 213-252.
57. SPENGLER, D., C. WAEBER, C. PANTALONI, F. HOLSBOER, J. BOCKAERT, P. H. SEEBURG & L. JOURNOT. 1993. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365: 170-175.
58. STEPHENSON, R. P. 1956. A modification of receptor theory. Br. J. Pharmacol. 11: 379-393.
59. VANHOUTTE, P. M., P. P. A. HUMPHREY & M. SPEDDING. 1996. X. International Union of Pharmacology Recommendations for Nomenclature of New Receptor Subtypes. Pharmacol. Rev. 48: 1-2.
60. BYLUND, D. B., D. C. EIKENBERG, J. P. HIEBLE, S. Z. LANGER, R. J. LEFKOWITZ, K. P. MINNEMAN, P. B. MOLINOFF, R. R. RUFFOLO & U. TRENDELENBURG. 1994. IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol. Rev. 46: 121-136.
61. VANETTI, M., G. VOGT & V. HOLLT. 1993. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett. 331: 260-266.
62. q/11. Mol. Pharmacol. 45: 890-898.
63. GILMAN, A. G. 1995. G. proteins and regulation of adenylyl cyclase. Bioscience Reports 15: 65-97.